Cargando…
Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse
BACKGROUND: Fertility preservation is particularly challenging in young women diagnosed with hematopoietic cancers, as transplantation of cryopreserved ovarian cortex in these women carries the risk for re-introducing cancer cells. Therefore, the construction of a bioengineered ovary that can accomm...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376865/ https://www.ncbi.nlm.nih.gov/pubmed/32703228 http://dx.doi.org/10.1186/s12958-020-00630-y |
_version_ | 1783562114880765952 |
---|---|
author | Alshaikh, Ahmed Baker Padma, Arvind Manikantan Dehlin, Matilda Akouri, Randa Song, Min Jong Brännström, Mats Hellström, Mats |
author_facet | Alshaikh, Ahmed Baker Padma, Arvind Manikantan Dehlin, Matilda Akouri, Randa Song, Min Jong Brännström, Mats Hellström, Mats |
author_sort | Alshaikh, Ahmed Baker |
collection | PubMed |
description | BACKGROUND: Fertility preservation is particularly challenging in young women diagnosed with hematopoietic cancers, as transplantation of cryopreserved ovarian cortex in these women carries the risk for re-introducing cancer cells. Therefore, the construction of a bioengineered ovary that can accommodate isolated small follicles was proposed as an alternative to minimize the risk of malignancy transmission. Various options for viable bioengineered scaffolds have been reported in the literature. Previously, we reported three protocols for producing mouse ovarian scaffolds with the decellularization technique. The present study examined these scaffolds further, specifically with regards to their extracellular composition, biocompatibility and ability to support recellularization with mesenchymal stem cells. MATERIAL AND METHODS: Three decellularization protocols based on 0.5% sodium dodecyl sulfate (Protocol 1; P1), or 2% sodium deoxycholate (P2), or a combination of the two detergents (P3) were applied to produce three types of scaffolds. The levels of collagen, elastin and sulfated glycosaminoglycans (sGAGs) were quantified in the remaining extracellular matrix. Detailed immunofluorescence and scanning electron microscopy imaging were conducted to assess the morphology and recellularization efficiency of the constructs after 14 days in vitro utilizing red fluorescent protein-labelled mesenchymal stem cells. RESULTS: All protocols efficiently removed the DNA while the elastin content was not significantly reduced during the procedures. The SDS-protocol (P1) reduced the sGAG and the collagen content more than the SDC-protocol (P2). All scaffolds were biocompatible and recellularization was successful, particularly in several P2-derived scaffolds. The cells were extensively distributed throughout the constructs, with a denser distribution observed towards the ovarian cortex. The cell density was not significantly different (400 to 550 cells/mm(2)) between scaffold types. However, there was a tendency towards a higher cell density in the SDC-derived constructs. Scanning electron microscope images showed fibrous scaffolds with a dense repopulated surface structure. CONCLUSIONS: While there were differences in the key structural macromolecules between protocols, all scaffolds were biocompatible and showed effective recellularization. The results indicate that our SDC-protocol might be better than our SDS-protocol. However, additional studies are necessary to determine their suitability for attachment of small follicles and folliculogenesis. |
format | Online Article Text |
id | pubmed-7376865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73768652020-07-23 Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse Alshaikh, Ahmed Baker Padma, Arvind Manikantan Dehlin, Matilda Akouri, Randa Song, Min Jong Brännström, Mats Hellström, Mats Reprod Biol Endocrinol Research BACKGROUND: Fertility preservation is particularly challenging in young women diagnosed with hematopoietic cancers, as transplantation of cryopreserved ovarian cortex in these women carries the risk for re-introducing cancer cells. Therefore, the construction of a bioengineered ovary that can accommodate isolated small follicles was proposed as an alternative to minimize the risk of malignancy transmission. Various options for viable bioengineered scaffolds have been reported in the literature. Previously, we reported three protocols for producing mouse ovarian scaffolds with the decellularization technique. The present study examined these scaffolds further, specifically with regards to their extracellular composition, biocompatibility and ability to support recellularization with mesenchymal stem cells. MATERIAL AND METHODS: Three decellularization protocols based on 0.5% sodium dodecyl sulfate (Protocol 1; P1), or 2% sodium deoxycholate (P2), or a combination of the two detergents (P3) were applied to produce three types of scaffolds. The levels of collagen, elastin and sulfated glycosaminoglycans (sGAGs) were quantified in the remaining extracellular matrix. Detailed immunofluorescence and scanning electron microscopy imaging were conducted to assess the morphology and recellularization efficiency of the constructs after 14 days in vitro utilizing red fluorescent protein-labelled mesenchymal stem cells. RESULTS: All protocols efficiently removed the DNA while the elastin content was not significantly reduced during the procedures. The SDS-protocol (P1) reduced the sGAG and the collagen content more than the SDC-protocol (P2). All scaffolds were biocompatible and recellularization was successful, particularly in several P2-derived scaffolds. The cells were extensively distributed throughout the constructs, with a denser distribution observed towards the ovarian cortex. The cell density was not significantly different (400 to 550 cells/mm(2)) between scaffold types. However, there was a tendency towards a higher cell density in the SDC-derived constructs. Scanning electron microscope images showed fibrous scaffolds with a dense repopulated surface structure. CONCLUSIONS: While there were differences in the key structural macromolecules between protocols, all scaffolds were biocompatible and showed effective recellularization. The results indicate that our SDC-protocol might be better than our SDS-protocol. However, additional studies are necessary to determine their suitability for attachment of small follicles and folliculogenesis. BioMed Central 2020-07-23 /pmc/articles/PMC7376865/ /pubmed/32703228 http://dx.doi.org/10.1186/s12958-020-00630-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Alshaikh, Ahmed Baker Padma, Arvind Manikantan Dehlin, Matilda Akouri, Randa Song, Min Jong Brännström, Mats Hellström, Mats Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse |
title | Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse |
title_full | Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse |
title_fullStr | Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse |
title_full_unstemmed | Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse |
title_short | Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse |
title_sort | decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376865/ https://www.ncbi.nlm.nih.gov/pubmed/32703228 http://dx.doi.org/10.1186/s12958-020-00630-y |
work_keys_str_mv | AT alshaikhahmedbaker decellularizationandrecellularizationoftheovaryforbioengineeringapplicationsstudiesinthemouse AT padmaarvindmanikantan decellularizationandrecellularizationoftheovaryforbioengineeringapplicationsstudiesinthemouse AT dehlinmatilda decellularizationandrecellularizationoftheovaryforbioengineeringapplicationsstudiesinthemouse AT akouriranda decellularizationandrecellularizationoftheovaryforbioengineeringapplicationsstudiesinthemouse AT songminjong decellularizationandrecellularizationoftheovaryforbioengineeringapplicationsstudiesinthemouse AT brannstrommats decellularizationandrecellularizationoftheovaryforbioengineeringapplicationsstudiesinthemouse AT hellstrommats decellularizationandrecellularizationoftheovaryforbioengineeringapplicationsstudiesinthemouse |